Genesis Research Group, a Hoboken-based international healthcare consultancy, has announced three key executive appointments aimed at strengthening the firm’s capabilities in market access, pricing, and strategic commercialization. With decades of combined experience across the United States, Europe, and the Asia-Pacific region, these industry veterans bring a wealth of knowledge to support pharmaceutical, biotechnology, and medical device companies in navigating complex healthcare markets.
Founded in 2009 and acquired by London-based GHO Capital in 2021, Genesis Research Group has established itself as a leading provider of real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services. The company partners with life sciences organizations to communicate the clinical and commercial value of their products to regulators, payers, and healthcare stakeholders worldwide.
The consultancy offers a broad range of services, including the development of value dossiers, manuscripts, abstracts, and regulatory submission materials, all designed to demonstrate the tangible impact of medical innovations. Genesis Research Group combines expert human analysis with proprietary technology platforms such as EVID AI, an artificial intelligence-powered literature review system, and the Rapid Payer Response (RPR) platform, which delivers actionable insights from a network of over 3,500 global healthcare professionals.
The firm’s “data-agnostic” approach ensures that recommendations are based on the most relevant and diverse datasets available globally, rather than being confined to limited sources. This methodology allows Genesis Research Group to provide truly independent, evidence-based guidance tailored to each client’s research and market access needs.
The recent leadership appointments are a strategic move to expand the company’s capacity for guiding healthcare clients through increasingly complex regulatory environments, competitive pricing pressures, and evolving payer landscapes. These executives will play a critical role in helping life sciences companies optimize their commercialization strategies while accelerating patient access to innovative treatments.
Genesis Research Group’s vision focuses on transforming healthcare research into actionable insights that drive better patient outcomes. By integrating technology with human expertise, the firm continues to support companies in navigating the global healthcare ecosystem with precision and efficiency.
For those interested in the latest developments in New Jersey’s business landscape and the healthcare sector, visit Explore New Jersey Business to learn more about innovative companies, strategic growth initiatives, and industry trends shaping the Garden State.
With these new appointments, Genesis Research Group reinforces its position as a global leader in healthcare consultancy, providing life sciences organizations with the tools and insights they need to demonstrate value, influence policy, and improve patient access worldwide.
